Vingroup spent money on 1,000 Vietnamese genome sequences

The project kicked off in early 2019. When gene data is available, it will help researchers find their own treatment regimens.

The Big Data Research Institute of Vintech (Vingroup) kicked off its first project after 4 months of launch under the management of Prof. Vu Ha Van.

This is a project about the genome that is believed to be the largest in Southeast Asia with an investment cost of 4.5 million USD. Implementing this project, there will be 1,000 Vietnamese people who will be able to solve the whole genome sequence to create a fundamental data source for Vietnamese gene research for domestic and foreign research communities.

The study will start in early 2019, lasting for 5 years divided into 2 phases.

This is a project about the genome that is believed to be the largest in Southeast Asia.(Artwork: ST).

In the first stage (the first 3 years), scientists will deploy collecting samples of 1,000 Vietnamese people, along with partners in the US, Germany, Singapore and Japan to explain and analyze the entire genome, set up Database of genetic variation for Vietnamese populations.

From this database, scientists will build more mutated (panel) lists for correlation studies across the genome, genetic and pharmacological studies of genetics ( PGx).

To serve the study, Vingroup said it would invest in modern analytical systems and large data storage systems to meet the needs of analysis and storage.

Professor Vu Ha Van, scientific director of the Big Data Research Institute, said that gene data is a premise for research in phase 2 and provides a foundation for other genetic research in Vietnam.

"The project will contribute greatly to the research community on gene-related issues in Vietnam," said Prof. Vu Ha Van.

In phase 2, the project focuses on genome-wide correlation studies to develop laboratory methods for some genetic diseases and adverse drug reactions.

Currently the project team has collaborated with researchers on genetics and genetic diseases in the US, Germany and Japan .

In the field of genetics pharmacology (PGx), the team is cooperating with research groups in Southeast Asia, including Singapore, Thailand, and Japan as pioneers in clinical PGx applications. .

Building and analyzing the human genome has a great impact on many different areas, including medicine, pharmacology, biotechnology and anthropology. Genetic studies help in the detection, warning, and early treatment of a number of diseases, as well as help develop individualized methods of diagnosis and treatment.

Before that, after the launching ceremony of the Big Data Research Institute, Prof. Vu Ha Van shared the aspiration to build industry data so that people in the country could approach and overseas experts could use it. at any time

Accordingly, the health, agriculture, and transportation sectors will be gradually applied technology to build data in standard form.